Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2016-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2015.12.101PMID 26755394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer.

  2015cited by this paper
• Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase

  2015cited by this paper
• Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.

  2013cited by this paper
• Metabolic targets for cancer therapy

  2013cited by this paper
• Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors.

  2013cited by this paper
• Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors.

  2013cited by this paper
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cited by this paper
• The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer.

  2010cited by this paper
• Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data

  2010cited by this paper
• Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.

  2010cited by this paper
• Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777

  2009cited by this paper
• Nampt: linking NAD biology, metabolism and cancer.

  2009cited by this paper
• The Small Molecule GMX1778 Is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors

  2009cited by this paper
• The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor

  2008cited by this paper
• Sirtuins: critical regulators at the crossroads between cancer and aging

  2007cited by this paper
• Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents

  2006cited by this paper
• Introduction to poly(ADP-ribose) metabolism.

  2005cited by this paper
• Enzymology of NAD+ homeostasis in man

  2003cited by this paper
• FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.

  2003cited by this paper
• Niacin, poly(ADP-ribose) polymerase-1 and genomic stability.

  2001cited by this paper
• Enhancement of poly‐adenosine diphosphate‐ribosylation in human hepatocellular carcinoma

  2000cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems

  1980cited by this paper
• The Nicotinamide Phosphoribosyltransferase: a Molecular Link between Metabolism, Inflammation, and Cancer the Key Role of Nicotinamide Phosphoribosyl- Transferase in Nicotinamide Adenine Dinucleotide Metabolism

  year unknowncited by this paper

• Cascade heteroarylation/annulation of arylphosphonic acid monoesters with benzothiophenes: access to benzothieno-fused oxaphosphacycles.

  2025cites this paper
• Exploring the Enzyme Inhibition Potential of Schiff Base and Metal Complexes of Benzothiophene Derivatives

  2024cites this paper
• Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy.

  2024cites this paper
• Field-based 3D-QSAR studies on amide- and urea-containing NAMPT inhibitors

  2023cites this paper
• Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT.

  2022cites this paper
• Sulphur Containing Heterocyclic Compounds as Anticancer Agents.

  2022cites this paper
• Synthesis of a New Class of Spirooxindole–Benzo[b]Thiophene-Based Molecules as Acetylcholinesterase Inhibitors

  2020cites this paper
• Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy

  2020cites this paper
• Recent Progress in the Synthesis of Benzo[b]thiophene

  2020cites this paper
• Nicotinamide phosphoribosyltransferase is a molecular target of potent anticancer agents identified from phenotype-based drug screening

  2019cites this paper
• Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide.

  2019cites this paper
• Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening.

  2019cites this paper
• The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention.

  2018cites this paper
• Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors.

  2017cites this paper
• An overview of benzo[b]thiophene-based medicinal chemistry.

  2017cites this paper
• Insights into the Link Between Obesity and Cancer

  2017cites this paper